Parkin Ligase Activation Methods And Compositions

Abstract

The present invention is directed to methods and compositions for activating a Parkin ligase by administering to a subject in need thereof a therapeutically effective amount of a compound that disrupts at least one Parkin ligase zinc finger. The present invention is also directed to methods of treating and/or reducing the incidence of diseases or conditions related to the activation of Parkin ligase.


Claims
Download PDF
Document Preview
Document History
  • Publication: Dec 18, 2018
  • Application: Dec 7, 2015
    US US 201514961285 A
  • Priority: Dec 7, 2015
    US US 201514961285 A
  • Priority: Oct 5, 2015
    US US 201562237400 P
  • Priority: Sep 22, 2015
    US US 201562222008 P
  • Priority: Dec 5, 2014
    US US 201462087972 P

Download Citation


Sign in to the Lens

Feedback